SpringWorks Therapeutics grabs $125 mln Series B

Stamford, Connecticut-based SpringWorks Therapeutics Inc, a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, has raised $125 million in Series B financing. Perceptive Advisors led the round.

Source: Press Release